ENST00000526761.5:n.*320+6982T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000526761.5(CLNS1A):n.*320+6982T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 152,116 control chromosomes in the GnomAD database, including 5,455 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 5455 hom., cov: 33)
Consequence
CLNS1A
ENST00000526761.5 intron
ENST00000526761.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.231
Publications
3 publications found
Genes affected
CLNS1A (HGNC:2080): (chloride nucleotide-sensitive channel 1A) This gene encodes a protein that functions in multiple regulatory pathways. The encoded protein complexes with numerous cytosolic proteins and performs diverse functions including regulation of small nuclear ribonucleoprotein biosynthesis, platelet activation and cytoskeletal organization. The protein is also found associated with the plasma membrane where it functions as a chloride current regulator. Pseudogenes of this gene are found on chromosomes 1, 4 and 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
PAK1 (HGNC:8590): (p21 (RAC1) activated kinase 1) This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]
PAK1 Gene-Disease associations (from GenCC):
- intellectual developmental disorder with macrocephaly, seizures, and speech delayInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PAK1 | XM_024448560.2 | c.-377+6982T>C | intron_variant | Intron 1 of 16 | XP_024304328.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLNS1A | ENST00000526761.5 | n.*320+6982T>C | intron_variant | Intron 5 of 5 | 3 | ENSP00000475218.1 |
Frequencies
GnomAD3 genomes AF: 0.254 AC: 38646AN: 151996Hom.: 5442 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38646
AN:
151996
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.254 AC: 38704AN: 152116Hom.: 5455 Cov.: 33 AF XY: 0.262 AC XY: 19489AN XY: 74360 show subpopulations
GnomAD4 genome
AF:
AC:
38704
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
19489
AN XY:
74360
show subpopulations
African (AFR)
AF:
AC:
9801
AN:
41478
American (AMR)
AF:
AC:
6318
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
962
AN:
3466
East Asian (EAS)
AF:
AC:
1648
AN:
5166
South Asian (SAS)
AF:
AC:
2342
AN:
4830
European-Finnish (FIN)
AF:
AC:
2127
AN:
10580
Middle Eastern (MID)
AF:
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14442
AN:
68006
Other (OTH)
AF:
AC:
524
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1454
2907
4361
5814
7268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1471
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.